Skip to main content
SpringerLink
Log in

Cromer System

  • Chapter
Human Blood Groups

  • 325 Accesses

Abstract

Seven high-frequency and three low-frequency antigens of the Cromer system have been described (Table 21.1). Dimorphic variations are represented by Tca and Tc c in Europids, Tc a and Tc b in Negrids, and WES a and WES b in Negrids and Finns.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Asch, A. S., Kinoshita, T., Jaffe, E. A. & Nussenzweiq, V. (1986): Decay-accelerating factor is present on cultured human umbilical vein endothelial cells. J. Exp. Med. 163, 221–226.

    Article  PubMed  CAS  Google Scholar 

  2. Bergelson, J. M., Chan, M., Solomon, K. R., John, N. F. S., Lin, H. & Finberg, R. W. (1994): Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. USA 91, 6245–6248.

    Article  PubMed  CAS  Google Scholar 

  3. Bergelson, J. M., Mohanty, J. G., Crowell, R. L., John, N. F. S., Lublin, D. M. & Finberg, R. W. (1995): Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J. Virol. 69, 1903–1906.

    PubMed  CAS  Google Scholar 

  4. Brodbeck, W. G., Liu, D. C., Sperry, J., Mold, C. & Medof, M. E. (1996): Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. J. Immunol. 156, 2528–2533.

    PubMed  CAS  Google Scholar 

  5. Caras, I. W., Davitz, M. A., Rhee, G., Weddeul, G. N., Martin, D. W. & Nussenzweig, V. (1987): Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325, 545–549.

    Article  PubMed  CAS  Google Scholar 

  6. Coyne, K. E., Hall, S. E., Thompson, E. S., Arce, m. A., Kinoshita, T., Fujita, T., Anstee, D. J., Rosse, W. & Lublin, D. M. (1992): Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J. Immunol. 149, 2906–2913.

    PubMed  CAS  Google Scholar 

  7. Daniels, G. (1989): Cromer-related antigens — blood group determinants on decay-accelerating factor. Vox Sang. 56, 205–211.

    Article  PubMed  CAS  Google Scholar 

  8. Daniels, G. & Walthers, L. (1986): Anti-IFC, an antibody made by Inab phenotype individuals. Transfusion 26, 117–118.

    Article  PubMed  CAS  Google Scholar 

  9. Daniels, G. L., Green, C. A., Darr, F. W., Anderson, H. & Sistonen, P. (1987): A ‘new’ Cromer-related high frequency antigen probably antithetical to WES. Vox Sang. 53, 235–238.

    Article  PubMed  CAS  Google Scholar 

  10. Daniels, G. L., Tohyama, H. & Uchikawa, M. (1982): A possible null phenotype in the Cramer blood group complex. Transfusion 22, 362–363.

    Article  PubMed  CAS  Google Scholar 

  11. Karnauchow, T. M., Tolson, D. L., Harrison, B. A., Altman, E., Lublin, D. M. & Dimock, K. (1996): The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J. Virol. 70, 5143–5152.

    PubMed  CAS  Google Scholar 

  12. Kinoshita, T., Medof, M. E., Silber, R. & Nussenzweig, V. (1985): Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J. Exp. Med. 162, 75–92.

    Article  PubMed  CAS  Google Scholar 

  13. Kuttner-Kondo, L., Medof, M. E., Brodbeck, W. & Shoham, M. (1996): Molecular modeling and mechanism of action of human decay-accelerating factor. Protein Eng. 9, 1143–1149.

    Article  PubMed  CAS  Google Scholar 

  14. Lacey, P. A., Block, U. T., Laird-Fryer, B. J., Moulds, J. J., Bryant, L R., Giandelone, J. A. & Linnemeyer, D. R. (1985): Anti-Tcb, an antibody that defines a red cell antigen antithetical to Tca. Transfusion 25, 373–376.

    Article  PubMed  CAS  Google Scholar 

  15. Laird-Fryer, B., Dukes, C. V., Lawson, J., Moulds, J. J., Walker, E. M. & Glassman, A. B. (1983): Tca: a high frequency blood group antigen. Transfusion 23, 124–127.

    Article  PubMed  CAS  Google Scholar 

  16. Law, J., Judge, A., Covert, P., Lewis, N., Sabo, B. & Mccreary, J. (1982): A new low frequency factor proposed to be the product of an allele to Tca. (Abstract). Transfusion 22, 413.

    Google Scholar 

  17. Levene, C., Harel, N., Kende, G., Papo, S., Bradford, M. F. & Daniels, G. L. (1987): A second Dr(a-) proposita with anti-Dr” and a family with Dr(a-) in 2 generations. Transfusion 27, 64–65.

    Article  PubMed  CAS  Google Scholar 

  18. Levene, C., Harel, N., Lavie, G., Greenberg, S., Laird-Fryer, B. & Daniels, G. L. (1984): A ‘new’ phenotype confirming a relationship between Cra and Tca. Transfusion 24, 13–15.

    Article  PubMed  CAS  Google Scholar 

  19. Lewis, M., Anstee, D. J., Brid, G. W. G., Brodheim, E., Cartron, J. P., Contreras, M., Crookston, M. C., Dahr, W., Daniels, G. L., Engelfriet, C. P., Giles, C. M., Issitt, P. D., J0Rgensen, J., Kornstad, L., Lubenko, A., Marsh, W. L., Mccreary, J., Moore, B. P. L., Morel, P., Moulds, J. J., Nevanunna, H., Nordhagen, R., Okubo, Y., Rosenfield, R. E., Rouger, P., Rubinstein, P., Salmon, C., Seidl, S., Sistonen, P., Tippett, P., Walker, R. H., Woodfield, G. & Young, S. (1990): Blood group terminology 1990. Vox Sang. 58, 152–169.

    Article  Google Scholar 

  20. Lin, R. C., Herman, J., Henry, L. & Daniels, G. L. (1988): A family showing inheritance of the Inab phenotype. Transfusion 28, 427–429.

    Article  PubMed  CAS  Google Scholar 

  21. Lublin, D. M. & Atkinson, J. P. (1989): Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7, 35–58.

    Article  PubMed  CAS  Google Scholar 

  22. Lublin, D. M., Krsek-Staples, J., Pangburn, M. K. & Atkinson, J. P. (1986): Biosynthesis and glycosylation of the human complement regulatory protein decay accelerating factor. J. Immunol. 137, 1629–1635.

    PubMed  CAS  Google Scholar 

  23. Lublin, D. M., Lemons, R. S., Le Beau, M. M., Holers, V. M., Tykocinski, M. L., Medof, M. E. & Atkinson, J. P. (1987): The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1. J. Exp. Med. 165, 1731–1736.

    Article  PubMed  CAS  Google Scholar 

  24. Lublin, D. M., Mallinson, G., Poole, J., Reid, M. E., Thompson, E. S., Ferdman, B. R., Telen, M. J., Anstee, D. J. & Tanner, M. J. A. (1994): Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 84, 1276–1282.

    PubMed  CAS  Google Scholar 

  25. Lublin, D. M., Thompson, E. S., Green, A. M., Levene, C. & Telen, M. J. (1991): Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants. J. Clin. Invest. 87, 1945–1952.

    Article  PubMed  CAS  Google Scholar 

  26. Medof, M. E., Lublin, D. M., Holers, V. M., Ayers, D. J., Getty, R. R., Leykam, J. F., Atkinson, J. P. & Tykocinski, M. L. (1987): Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc. Natl. Acad. Sci. USA 84, 2007–2011.

    Article  PubMed  CAS  Google Scholar 

  27. Medof, M. E., Walter, E. I., Rutgers, J. L., Knowles, D. M. & Nussenzweig, V. (1987): Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J. Exp. Med. 165, 848–864.

    Article  PubMed  CAS  Google Scholar 

  28. Nicholson-Weller, A., Bürge, J., Fearon, D. T., Weller, D. T. & Austen, K. F. (1982): Isolation of human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J. Immunol. 129, 184–189.

    PubMed  CAS  Google Scholar 

  29. Nicholson-Weller, A., March, J. P., Rosen, C. E., Spicer, D. B. & Austen, K. F. (1985): Surface membrane expression by human blood leukocytes and platelets of decay-accelerating factor, a regulatory protein of the complement system. Blood 69, 1237–1244.

    Google Scholar 

  30. Nowicki, B., Moulds, J., Hull, R. & Hull, S. (1988): A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen. Infect. Immun. 56, 1057–1060.

    PubMed  CAS  Google Scholar 

  31. Petty, A. C., Daniels, G. L., Anstee, D. J. & Tippett, P. (1993): Use of the MAIEA technique to confirm the relationship between the Cromer antigens and decay-accelerating factor and to assign provisionally antigens to the short-consensus repeats. Vox Sang. 65, 309–315.

    Article  PubMed  CAS  Google Scholar 

  32. Post, T. W., Arce, M. A., Liszewski, M. K., Thompson, E. S., Atkinson, J. P. & Lublin, D. M. (1990): Structure of the gene for human complement protein decay acceleration factor. J. Immunol. 144, 740–744.

    PubMed  CAS  Google Scholar 

  33. Reid, M. E., Mallinson, G., Sim, R. B., Poole, J., Pausch, V., Merry, A. H., Liew, Y. W. & Tanner, M. J. A. (1991): Biochemical studies on red blood cells from a patient with the Inab phenotype (decay-accelerating factor deficiency). Blood 78, 3291–3297.

    PubMed  CAS  Google Scholar 

  34. Rey-Campos, J., Rubinstein, P. & Rodriguez De Cordoba, S. (1987): Decay accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans. J. Exp. Med. 166, 246–252.

    Article  PubMed  CAS  Google Scholar 

  35. Slstonen, P., Nevanlinna, H. R., Virtaranta-Knowles, K., Tuominen, I., Plrkola, A., Green, C. A. & Tippett, P. (1987): WES, a ‘new’ infrequent blood group antigen in Finns. Vox Sang. 52, 111–114.

    Article  Google Scholar 

  36. Spring, F. A., Judson, P. A., Daniels, G. L., Parsons, S. F., Mallinson, G. & Anstee, D. J. (1987): A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets. Immunology 62, 307–313.

    PubMed  CAS  Google Scholar 

  37. Stroup, M. & Mccreary, J. (1975): Cr” another high frequency blood group factor. (Abstract). Transfusion 15, 522.

    Google Scholar 

  38. Täte, G., Uchikawa, M., Tanner, M. J. A., Judson, P. A., Parsons, S. F., Mallinson, G. & Anstee, D. J. (1989): Studies on the defect which causes absence of decay accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotype. Biochem. J. 261, 489–493.

    PubMed  Google Scholar 

  39. Telen, M. J., Hall, S. E., Green, A. M., Moulds, J. J. & Rosse, W. F. (1988): Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J. Exp. Med. 167, 1993–1998.

    Article  PubMed  CAS  Google Scholar 

  40. Telen, M. J., Rao, N. & Lublin, D. M. (1995): Location of WES” on decay-accelerating factor. Transfusion 35, 278.

    Article  PubMed  CAS  Google Scholar 

  41. Telen, M. J., Rao, N., Udani, M., Thompson, E. S., Kaufman, R. M. & Lublin, D. M. (1994): Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 84, 3205–3211.

    PubMed  CAS  Google Scholar 

  42. Tregellas, W. M. (1984): Description of a new blood group antigen, Esa. 18th Congress of the International Society of Blood Transfusion, Karger, Basel, Abstracts p. 163.

    Google Scholar 

  43. Walthers, L., Salem, M., Tessel, J., Laird-Fryer, B. & Moulds, J. J. (1983): The Inab phenotype: another example found. (Abstract). Transfusion 23, 423.

    Google Scholar 

  44. Wang, L., Uchikawa, M., Tsuneyama, H., Tokunaga, K., Tadokoro, K. & Juji, T. (1998): Molecular cloning and characterization of decay-accelerating factor deficiency in Cromer blood group Inab phenotype. Blood 91, 680–684.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Medizinische Biochemie, Universität Wien, Vienna, Austria

    Dr. Helmut Schenkel-Brunner

Authors
  1. Dr. Helmut Schenkel-Brunner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Wien

About this chapter

Cite this chapter

Schenkel-Brunner, H. (2000). Cromer System. In: Human Blood Groups. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6294-1_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6294-1_21

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7244-5

  • Online ISBN: 978-3-7091-6294-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation